Furthermore, CKS1B accelerates chemotherapeutic resistance in many types of cancers, while a decrease in CKS1B makes these tumor cells sensitive to chemotherapeutic drugs, suggesting that CKS1B is a promising treatment target in cancers. This evidence concerns the gene CKS1B and cancer.